Carter Bankshares Q2 Earnings: $1.31 EPS Crushes Consensus, Insurance Sale and Portfolio Repositioning Reshape Balance Sheet
CARE sits 95% above its 52-week low of $16.78.
Summary
Carter Bankshares reported Q2 2026 EPS of $1.31, far above the $0.76 consensus, fueled by a $35.9M gain on the sale of its insurance unit. Core net interest margin expanded to 3.38%, and the company repositioned its securities portfolio to enhance future returns. Nonperforming loans rose modestly, but capital levels and tangible book value improved.
Key Events · Earnings and Guidance · CARE
-
Q2 EPS of $1.31 Crushes Estimates
Driven by a $35.9M pre-tax gain on the sale of Bearing Insurance Group, diluted EPS reached $1.31, significantly above the $0.76 consensus. Adjusted net income was $11.6M, or $0.53 per share.
-
Net Interest Margin Expands to 3.38%
Net interest income rose 11.2% sequentially to $40.0M, with net interest margin improving 31 basis points to 3.38%, reflecting lower funding costs and higher asset yields.
-
Insurance Sale and Portfolio Repositioning Completed
The sale of Bearing Insurance Group was completed for a $35.9M gain, and the securities portfolio was repositioned by selling $139.4M of low-yield securities and buying $88.5M of higher-yield securities, incurring a $12.5M loss but improving future earnings potential.
-
Nonperforming Loans Increase to $37.6M
Nonperforming loans rose to $37.6M (1.01% of portfolio loans) from $24.0M in Q1, primarily due to a $13.4M commercial and industrial relationship placed on nonaccrual. Allowance coverage remains strong at 146.88%.
Analysis · CARE · Finance
A massive Q2 beat propelled Carter Bankshares to EPS of $1.31, far outpacing the $0.76 consensus, thanks largely to a $35.9 million gain from the sale of its insurance subsidiary. Core operating performance also strengthened: net interest margin expanded 31 basis points sequentially to 3.38%, and adjusted net income rose to $11.6 million from $8.6 million in Q1. The quarter included a strategic securities portfolio repositioning that incurred a $12.5 million loss but is expected to boost future yields. Credit quality showed a mixed picture—nonperforming loans ticked up to $37.6 million due to a single $13.4 million commercial relationship, but the allowance coverage remains strong at 147%. Capital ratios improved further, and the company repurchased $2.9 million in stock. The results confirm the bank is successfully deploying the capital generated from its first-quarter loan sale and insurance divestiture to strengthen its balance sheet and earnings power.
At the time of this filing, CARE was trading at $32.66 on NASDAQ in the Finance sector, with a market capitalization of approximately $731.5M. The 52-week trading range was $16.78 to $35.03. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.